EX-99 2 exhibit_99-1.htm EXHIBIT 99.1

Exhibit 99.1

Press Release
 
Eltek Ltd. Reports 2023 Third Quarter Financial Results
 
Petach Tikva, Israel (November 16, 2023) Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs), today announced its financial results for the quarter ended September 30, 2023.
 
Third Quarter 2023 Highlights
 

 ◾
Revenues were $11.9 million, up 15% over Q3 2022
 

 ◾
Operating profit was $2.3 million, up 105% over Q3 2022
 

 ◾
Profit before tax was $2.6 million compared to $1.2 million at Q3 2022.
 

 ◾
Net income was $2.1 million or $0.36 per fully diluted share, up 114% over Q3 2022
 

 ◾
As of September 30, 2023, cash and cash equivalents amounted $11.3 million compared to $8.3 million at the end of the previous quarter.
 
"In the third quarter of 2023, we achieved impressive financial results. We generated $11.9 million in revenue, leading to a robust gross profit of $3.7 million and a net profit of $2.1 million. These exceptional numbers reflect the strong market demand for our products, underpinned by our efficient order selection, which strikes a balance between maximizing profitability and aligning with our production capabilities. As of the end of the quarter, our cash and cash equivalents stood at $11.3 million, providing substantial financial support for our upcoming capital expenditure needs," said Eli Yaffe, CEO of Eltek.

"The ongoing conflict in Israel underscores the critical significance of a domestic PCB industry. Such an industry would not only offer advanced technological solutions but also produce intricate circuits tailored to specific defense requirements, employing state-of-the-art technology, and ensuring the highest quality standards. Additionally, it would enable swift delivery to meet the immediate demands of the defense sector. Eltek holds the status of an Essential Enterprise as designated by the Israeli government, granting us permission to operate around the clock, 365 days a year, as needed," continued Mr. Yaffe.

"Over the past weeks, and up to the present moment, we have maintained seamless operations without any disruptions. In certain instances, we've even accelerated the delivery of products to our valued customers. Our dedicated workforce remains fully engaged, reporting for duty on their regular schedules. We have implemented a series of strategic measures to ensure we meet our customers' demands. These includes securing commitments from our suppliers to continue delivering the essential raw materials to our facility in conformance with our orders, bolstering our inventory levels for selected raw materials and expediting the deliveries of crucial resources," continued Mr. Yaffe.

"Eltek management and employees bow their heads in memory of those killed in the murderous attack that happened on October 7, 2023. Our thoughts and prayers are with the injured for a speedy recovery and the safe return of those who were abducted," concluded Mr. Yaffe.


Third Quarter 2023 GAAP Financial Results
 
Revenues for the third quarter of 2023 were $11.9 million, compared to $10.3 million in the third quarter of 2022;
 
Gross profit for the third quarter of 2023 was $3.7 million (31% of revenues) compared to $2.4 million (23% of revenues) in the third quarter of 2022;
 
Operating profit for the third quarter of 2023 was $2.3 million compared to operating profit of $1.1 million in the third quarter of 2022;
 
Profit before income tax for the third quarter of 2023 was $2.6 million compared to $1.2 million in the third quarter of 2022;
 
Net income for the third quarter of 2023 was $2.1 million or $0.36 per fully diluted share compared to net income of $1.0 million or $0.17 per fully diluted share in the third quarter of 2022.
 
Third Quarter 2023 Non-GAAP Financial Results
 
EBITDA for the third quarter of 2023 was $2.6 million (22% of revenues) compared to EBITDA of $1.4 million (14% of revenues) in the third quarter of 2022.
 
First Nine Months 2023 GAAP Financial Results

Revenues for the first nine months of 2023 were $34.4 million compared to $29.2 million in the first nine months of 2022;
 
Gross profit for the first nine months of 2023 was $9.6 million (28% of revenues) compared to $6.1 million (21% of revenues) in the first nine months of 2022;
 
Operating profit for the first nine months of 2023 was $5.3 million compared to operating profit of $2.1 million in the first nine months of 2022;
 
Financial income for the first nine months of 2023 was $0.8 million compared to financial income of $0.8 million in the first nine months of 2022.
 
Profit before income tax for the first nine months of 2023 was $6.0 million compared to $2.9 million in the first nine months of 2022;
 
Net profit for the first nine months of 2023 was $5.0 million or $0.85 per fully diluted share compared to net profit of $2.4 million or $0.41 per fully diluted share in the first nine months of 2022.
 
First Nine Months 2023 Non-GAAP Financial Results
 
EBITDA for the first nine months of 2023 was a $6.2 million (18% of revenues) compared to EBITDA of $3.3 million (11% of revenues) in the first nine months of 2022.
 
About our Non-GAAP Financial Information
 
The Company reports financial results in accordance with U.S. GAAP and herein provides some non-GAAP measures, including EBITDA. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. These non-GAAP measures are intended to supplement the Company’s presentation of its financial results that are prepared in accordance with GAAP. The Company uses the non-GAAP measures presented to evaluate and manage the Company’s operations internally. The Company is also providing this information to assist investors in performing additional financial analysis. Reconciliation between the Company's results on a GAAP and non-GAAP basis is provided in the table below.
 
Conference Call
 
Today, Thursday, November 16, 2023, at 8:30am Eastern Time (15:30pm Israel Time, 5:30am Pacific Time), Eltek will conduct a conference call to discuss the results. The call will feature remarks by Eli Yaffe, Chief Executive Officer and Ron Freund, Chief Financial Officer.
 
To participate, please call the following teleconference numbers. Please allow for additional time to connect prior to the call:
 
United States:          1-866-860-9642
Israel:                      03-918-0691
International:          +972-3-918-0691

To Access a Replay of the Call
 
A replay of the call will be available for 30 days on the Investor Info section on Eltek’s corporate website at http://www.nisteceltek.com approximately 24 hours after the conference call is completed.
 
About Eltek
 
Eltek – ”Innovation Across the Board”, is a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs), and is an Israeli leading company in this industry. PCBs are the core circuitry of most electronic devices. Eltek specializes in the manufacture and supply of complex and high quality PCBs, HDI, multilayered and flex-rigid boards for the high-end market. Eltek is ITAR compliant and has AS-9100 and NADCAP Electronics certifications. Its customers include leading companies in the defense, aerospace and medical industries in Israel, the United States, Europe and Asia.
 
Eltek was founded in 1970. The Company’s headquarters, R&D, production and marketing center are located in Israel. Eltek also operates through its subsidiary in North America and by agents and distributors in Europe, India, South Africa and South America.
 
For more information, visit Eltek's web site at www.nisteceltek.com

Forward Looking Statement
 
Some of the statements included in this press release may be forward-looking statements that involve a number of risks and uncertainties including, but not limited to expected results in future quarters, the impact of the Coronavirus on the economy and our operations, risks in product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, market acceptance, the sales cycle, changing economic conditions and other risk factors detailed in the Company’s Annual Report on Form 20-F and other filings with the United States Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. The information found on our website is not incorporated by reference into this press release and is included for reference purposes only.
 
Investor Contact
 
Ron Freund
Chief Financial Officer
Investor-Contact@nisteceltek.com
+972-3-939-5023

(Tables follow)

Eltek Ltd.
Consolidated Statements of Income
(Unaudited, in thousands US$, except per share data)

   
Three months ended
    
Nine months ended
  
   
September 30,
    
September 30,
  
   
2023
    
2022
    
2023
    
2022
  
                         
Revenues
    
11,861
      
10,327
      
34,374
      
29,171
  
Costs of revenues
    
(8,182
)
    
(7,908
)
    
(24,728
)
    
(23,113
)
                                 
Gross profit
    
3,679
      
2,419
      
9,646
      
6,058
  
                                 
Selling, general and administrative expenses
    
(1,357
)
    
(1,261
)
    
(4,317
)
    
(3,859
)
R&D expenses, net
    
(12
)
    
(33
)
    
(36
)
    
(77
)
                                 
Operating profit
    
2,310
      
1,125
      
5,293
      
2,122
  
                                 
Financial income, net
    
279
      
55
      
756
      
787
  
                                 
Income before income tax
    
2,589
      
1,180
      
6,049
      
2,909
  
                                 
Taxes on income
    
442
      
176
      
1,027
      
520
  
                                 
Net income
    
2,147
      
1,004
      
5,022
      
2,389
  
                                 
Earnings per share:
                                
Basic and diluted net profit per ordinary share
    
0.36
      
0.17
      
0.85
      
0.41
  
                                 
Weighted average number of ordinary shares used to compute
                                
basic net profit per ordinary share (in thousands)
    
5,914
      
5,850
      
5,890
      
5,846
  
                                 
Weighted average number of ordinary shares used to compute
                                
diluted net profit per ordinary share (in thousands)
    
5,987
      
5,850
      
5,927
      
5,846
  

Eltek Ltd.
Consolidated Balance Sheets
(Unaudited, in thousands US$)

   
September 30,
    
December 31,
  
   
2023
    
2022
  
             
Assets
            
             
Current assets:
            
Cash and cash equivalents
    
11,305
      
7,366
  
Receivables:   Trade, net of provision for doubtful accounts
    
10,112
      
10,116
  
                       Other
    
719
      
282
  
Inventories
    
5,577
      
5,130
  
Prepaid expenses
    
228
      
504
  
                 
Total current assets
    
27,941
      
23,398
  
                 
Long term assets:
                
Restricted deposits
    
-
      
202
  
Severance pay fund
    
54
      
59
  
Deferred tax assets and long term tax receivables, net
    
1,299
      
2,496
  
Operating lease right of use assets
    
6,380
      
7,156
  
Total long term assets
    
7,733
      
9,913
  
                 
Fixed assets, less accumulated depreciation
    
6,601
      
7,674
  
                 
Total Assets
    
42,275
      
40,985
  
                 
Liabilities and Shareholder's equity
                
                 
Current liabilities:
                
Short-term credit and current maturities of long-term debts
    
-
      
702
  
Accounts payable: Trade
    
4,779
      
4,793
  
                              Other
    
5,962
      
4,133
  
Short-term operating lease liabilities
    
757
      
846
  
                 
Total current liabilities
    
11,498
      
10,474
  
                 
Long-term liabilities:
                
Long term debt, excluding current maturities
    
-
      
2,768
  
Employee severance benefits
    
291
      
280
  
Long-term operating lease liabilities
    
5,724
      
6,443
  
                 
Total long-term liabilities
    
6,015
      
9,491
  
                 
Shareholders' equity:
                
Ordinary shares of NIS 3.0 par value – Authorized: 10,000,000 shares at September 30, 2023 and December 31, 2022;
Issued and outstanding: 5,913,965 shares at September 30, 2023 and 5,849,678 shares at December 31, 2022
    
5,358
      
5,305
  
Additional paid-in capital
    
23,137
      
22,862
  
Cumulative foreign currency translation adjustments
    
(635
)
    
1,189
  
Capital reserve
    
1,753
      
1,537
  
Accumulated deficit
    
(4,851
)
    
(9,873
)
Total shareholders' equity
    
24,762
      
21,020
  
Total liabilities and shareholders' equity
    
42,275
      
40,985
  

Eltek Ltd.
Unaudited Non-GAAP EBITDA Reconciliations
(In thousands US$)

   
Three months ended
    
Nine months ended
  
   
September 30,
    
September 30,
  
   
2023
    
2022
    
2023
    
2022
  
                         
                         
GAAP Net Income
    
2,147
      
1,004
      
5,022
      
2,389
  
Add back items:
                                
                                 
Financial income, net
    
(279
)
    
(55
)
    
(756
)
    
(787
)
Income tax expenses
    
442
      
176
      
1,027
      
520
  
Depreciation and amortization
    
299
      
325
      
929
      
1,205
  
Non-GAAP EBITDA
    
2,609
      
1,450
      
6,222
      
3,327
  


Eltek Ltd.
Consolidated Statement of  Cash flow
(Unaudited, in thousands US$)

   
Three months ended
    
Nine months ended
  
   
September 30,
    
September 30,
  
   
2023
    
2022
    
2023
    
2022
  
                         
Cash flows from operating activities:
                        
                         
Net Income
    
2,147
      
1,004
      
5,022
      
2,389
  
Adjustments to reconcile net income to net cash flows provided by operating activities:
                                
Depreciation and amortization
    
299
      
325
      
929
      
1,205
  
Stock-based compensation
    
72
      
71
      
216
      
188
  
Decrease in deferred tax assets and long term tax receivable
    
432
      
170
      
998
      
499
  
     
803
      
566
      
2,143
      
1,892
  
                                 
Decrease (increase) in operating lease right-of-use assets
    
-
      
12
      
(22
)
    
8
  
Decrease (increase) in trade receivables
    
985
      
(1,208
)
    
(799
)
    
(3,488
)
Decrease (increase) in other receivables and prepaid expenses
    
87
      
311
      
(224
)
    
393
  
Decrease (increase) in inventories
    
(47
)
    
382
      
(856
)
    
(340
)
Increase (decrease) in trade payables
    
(74
)
    
371
      
31
      
1,143
  
Increase (decrease) in other liabilities and accrued expenses
    
(263
)
    
277
      
1,214
      
566
  
Increase (decrease)  in employee severance benefits, net
    
11
      
11
      
33
      
11
  
     
699
      
156
      
(623
)
    
(1,707
)
                                 
Net cash provided by operating activities
    
3,649
      
1,726
      
6,542
      
2,574
  
                                 
                                 
Cash flows from investing activities:
                                
Purchase of fixed assets
    
(475
)
    
(1,841
)
    
(1,186
)
    
(2,456
)
Insurance Proceeds
    
-
      
-
      
2,000
      
-
  
Restricted deposits
    
-
      
-
      
192
      
(2
)
Net cash provided by (used in) investing activities
    
(475
)
    
(1,841
)
    
1,006
      
(2,458
)
                                 
                                 
Cash flows from financing activities:
                                
Exercise of options
    
29
      
-
      
328
      
25
  
Repayment of long-term loans from bank
    
-
      
(181
)
    
(3,348
)
    
(432
)
Repayment of credit from fixed asset payables
    
-
      
(3
)
    
-
      
(10
)
Net cash provided by (used in) financing activities
    
29
      
(184
)
    
(3,020
)
    
(417
)
                                 
Effect of translation adjustments
    
(228
)
    
(100
)
    
(589
)
    
(1,135
)
                                 
Net increase (decrease) in cash and cash equivalents
    
2,975
      
(399
)
    
3,939
      
(1,436
)
                                 
Cash and cash equivalents at the beginning of the period
    
8,330
      
8,246
      
7,366
      
9,283
  
                                 
Cash and cash equivalents at the end of the period
    
11,305
      
7,847
      
11,305
      
7,847